Bone Morphogenetic Protein 2
"Bone Morphogenetic Protein 2" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A potent osteoinductive protein that plays a critical role in the differentiation of osteoprogenitor cells into OSTEOBLASTS.
| Descriptor ID |
D055396
|
| MeSH Number(s) |
D12.644.276.954.200.200 D12.776.467.942.200.200 D23.529.942.200.200
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Bone Morphogenetic Protein 2".
Below are MeSH descriptors whose meaning is more specific than "Bone Morphogenetic Protein 2".
This graph shows the total number of publications written about "Bone Morphogenetic Protein 2" by people in this website by year, and whether "Bone Morphogenetic Protein 2" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 0 | 1 | 1 |
| 2006 | 0 | 4 | 4 |
| 2009 | 2 | 0 | 2 |
| 2010 | 1 | 1 | 2 |
| 2011 | 0 | 4 | 4 |
| 2013 | 3 | 0 | 3 |
| 2014 | 2 | 0 | 2 |
| 2015 | 5 | 0 | 5 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2021 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Bone Morphogenetic Protein 2" by people in Profiles.
-
Prospective comparison of dysphagia following anterior cervical discectomy and fusion (ACDF) with and without rhBMP-2. Spine J. 2022 02; 22(2):256-264.
-
Select polyphenolic fractions from dried plum enhance osteoblast activity through BMP-2 signaling. J Nutr Biochem. 2018 05; 55:59-67.
-
Microsphere-based scaffolds encapsulating tricalcium phosphate and hydroxyapatite for bone regeneration. J Mater Sci Mater Med. 2016 Jul; 27(7):121.
-
Seroma observed 6 months after anterior lumbar interbody fusion that included use of recombinant bone morphogenetic protein 2. Spine J. 2015 Oct 01; 15(10):e33.
-
Response. J Neurosurg Pediatr. 2015 May; 15(5):546.
-
The efficacy of routine use of recombinant human bone morphogenetic protein-2 in occipitocervical and atlantoaxial fusions of the pediatric spine: a minimum of 12 months' follow-up with computed tomography. J Neurosurg Pediatr. 2015 Jul; 16(1):14-20.
-
Routine use of recombinant human bone morphogenetic protein-2 in posterior fusions of the pediatric spine and incidence of cancer. J Neurosurg Pediatr. 2015 Jul; 16(1):4-13.
-
The feasibility and safety of using sublaminar polyester bands in hybrid spinal constructs in children and transitional adults for neuromuscular scoliosis. J Neurosurg Pediatr. 2015 Mar; 15(3):328-37.
-
Nationwide practice patterns in the use of recombinant human bone morphogenetic protein-2 in pediatric spine surgery as a function of patient-, hospital-, and procedure-related factors. J Neurosurg Pediatr. 2014 Nov; 14(5):476-85.
-
Fixation with C-2 laminar screws in occipitocervical or C1-2 constructs in children 5 years of age or younger: a series of 18 patients. J Neurosurg Pediatr. 2014 Jul; 14(1):87-93.